TNON

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

Wall Street analysts forecast TNON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNON is 2.75 USD with a low forecast of 2.50 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Tenon Medical Inc revenue for the last quarter amounts to 1.17M USD, increased 32.24 % YoY.

Tenon Medical Inc. EPS for the last quarter amounts to -0.40 USD, decreased -88.98 % YoY.

Tenon Medical Inc (TNON) has 27 emplpoyees as of December 16 2025.

Today TNON has the market capitalization of 11.99M USD.